The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy

Author:

Psilopatis Iason1ORCID,Garmpis Nikolaos23ORCID,Garmpi Anna4,Vrettou Kleio5,Sarantis Panagiotis6ORCID,Koustas Evangelos6,Antoniou Efstathios A.23,Dimitroulis Dimitrios23,Kouraklis Gregory7,Karamouzis Michail V.6ORCID,Marinos Georgios8,Kontzoglou Konstantinos23,Nonni Afroditi9,Nikolettos Konstantinos10,Fleckenstein Florian N.1112ORCID,Zoumpouli Christina13,Damaskos Christos214ORCID

Affiliation:

1. Department of Gynecology, Charité—Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany

2. Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

3. Nikolaos Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

4. First Department of Propedeutic Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

5. Department of Cytopathology, Sismanogleio General Hospital, 15126 Athens, Greece

6. Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

7. Department of Surgery, Evgenideio Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

8. Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

9. First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

10. Obstetric and Gynecologic Clinic, Medical School, Democritus University of Thrace, 68110 Alexandroupolis, Greece

11. Department of Diagnostic and Interventional Radiology, Charité—Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany

12. Berlin Institute of Health, Charité—Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, 13353 Berlin, Germany

13. Department of Pathology, Sismanogleio General Hospital, 15126 Athens, Greece

14. Renal Transplantation Unit, Laiko General Hospital, 11527 Athens, Greece

Abstract

Cervical carcinoma is one of the most common cancers among women globally. Histone deacetylase inhibitors (HDACIs) constitute anticancer drugs that, by increasing the histone acetylation level in various cell types, induce differentiation, cell cycle arrest, and apoptosis. The aim of the current review is to study the role of HDACIs in the treatment of cervical cancer. A literature review was conducted using the MEDLINE and LIVIVO databases with a view to identifying relevant studies. By employing the search terms “histone deacetylase” and “cervical cancer”, we managed to identify 95 studies published between 2001 and 2023. The present work embodies the most up-to-date, comprehensive review of the literature centering on the particular role of HDACIs as treatment agents for cervical cancer. Both well-established and novel HDACIs seem to represent modern, efficacious anticancer drugs, which, alone or in combination with other treatments, may successfully inhibit cervical cancer cell growth, induce cell cycle arrest, and provoke apoptosis. In summary, histone deacetylases seem to represent promising future treatment targets in cervical cancer.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference141 articles.

1. American Cancer Society (2020). What Is Cervical Cancer?, American Cancer Society.

2. American Cancer Society (2023). Key Statistics for Cervical Cancer, American Cancer Society.

3. American Cancer Society (2020). Risk Factors for Cervical Cancer, American Cancer Society.

4. American Cancer Society (2020). Signs and Symptoms of Cervical Cancer, American Cancer Society.

5. American Cancer Society (2021). Treatment Options for Cervical Cancer, by Stage, American Cancer Society.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3